DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 7.64

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.74M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-27 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.80% 49% F 56% F
Dividend Return 0.35% 10% F 6% D-
Total Return -2.45% 44% F 54% F
Trailing 12 Months  
Capital Gain -8.28% 10% F 47% F
Dividend Return 3.01% 41% F 34% F
Total Return -5.28% 11% F 48% F
Trailing 5 Years  
Capital Gain 14.37% 34% F 55% F
Dividend Return 10.95% 24% F 20% F
Total Return 25.33% 28% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 5.78% 61% D- 56% F
Dividend Return 7.66% 61% D- 55% F
Total Return 1.88% 54% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 8.27% 65% D 92% A
Risk Adjusted Return 92.64% 85% B 94% A
Market Capitalization 0.17B 33% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.